Corcept Therapeutics: Cushing Syndrome trials

The registry lists 14 Cushing Syndrome studies with Corcept Therapeutics as lead sponsor. 0 are open to participants now and 6 have results posted.

Phase 1 1Phase 2 2Phase 3 5Phase 4 1No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of the Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal AdenomasCompletedNCT04308590Phase 3Results posted
• A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing SyndromeCompletedNCT03697109Phase 3Results posted
• Study to Evaluate CORT125134 in Participants With Cushing's SyndromeCompletedNCT02804750Phase 2Results posted
• Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's SyndromeCompletedNCT01371565Phase 3Results posted
• An Extension Study of CORLUX in the Treatment of Endogenous Cushing's SyndromeCompletedNCT00936741Phase 3Results posted
• A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's SyndromeCompletedNCT00569582Phase 3Results posted
• Study of the Prevalence of Endogenous Hypercortisolism in Patients With Resistant Hypertension (MOMENTUM)CompletedNCT06829537
• Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST)CompletedNCT05772169Phase 4
• Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy ParticipantsCompletedNCT05347979Phase 1
• Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing SyndromeActive, not recruitingNCT03604198Phase 2
• Retrospective Chart Review Study of Pediatric Patients Treated With Korlym for Cushing SyndromeTerminatedNCT03379363
• Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After SurgeryCompletedNCT02922257
• Retrospective Chart Review Study of Korlym for the Treatment of ACTH Independent Cushing's SyndromeCompletedNCT02663609
• A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of HypercortisolemiaTerminatedNCT00796783